PATENT CLAIM ANALYSIS

Application Number: 16229446
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["549", "355000"]

Abstract:
Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and, further, has no side effect on eyes such as ocular stimulating property (hyperemia, corneal clouding etc.), aqueous humor protein rise etc., it has high safety, and can be an excellent agent for preventing and/or treating glaucoma etc.

Claim (Index 1):
A compound of the following chemical formula: or a pharmaceutically acceptable salt or a solvate thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.36765
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15852493', '15180125', '14081286', '14587829', '13384383']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8386786312703643
- 35 USC 102 Novelty (BERT): 0.5845425675200184
- Combined Prediction Score: 0.8132650248953298
- Mean Citation Score: 614.492446
- Max Citation Score: 614.5357700000002
- Similarity Product: 369.15469003772085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test